TELA Form 3: Director Reports No Holdings as of 10/09/2025

TELA Bio director Betty Jo Rocchio filed an initial Form 3 reporting no securities beneficially owned as of 10/09/2025.

Rhea-AI Filing Summary

TELA Bio director Betty Jo Rocchio filed an initial Form 3 reporting no securities beneficially owned as of 10/09/2025. The filing lists her relationship to the issuer as a director and was signed by an attorney-in-fact on 10/10/2025. No non-derivative or derivative holdings are reported and Exhibit 24 (Power of Attorney) is attached.

Positive

• None.

Negative

• No beneficial ownership reported by a company director as of 10/09/2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the TELA (TELA) Form 3 filed by Betty Jo Rocchio report?

The Form 3 states no securities are beneficially owned by Betty Jo Rocchio as of 10/09/2025.

What is the relationship of the reporting person to TELA?

The filer is listed as a Director of TELA Bio, Inc.

Was the Form 3 signed and when?

The filing was signed by an attorney-in-fact, Megan Smeykal, on 10/10/2025.

Does the Form 3 show any derivative securities or options?

No. The filing reports no non-derivative or derivative securities beneficially owned.

Is there an exhibit attached to the Form 3?

Yes. Exhibit 24 (Power of Attorney) is listed in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/10/2025 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rocchio Betty Jo

(Last) (First) (Middle)

C/O TELA BIO, INC.

1 GREAT VALLEY PARKWAY, SUITE 24

(Street)

MALVERN PA 19355

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/09/2025

3. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Megan Smeykal, Attorney-in-Fact	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.